Navigation Links
Avicena to Advance Huntington's Disease Clinical Program into Phase III

Avicena Group, Inc. (OTC Bulletin Board: AVGO), a late stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases, announced today the selection of the optimal dose of HD-02, its novel drug candidate for the treatment of Huntington's Disease.

This dose was determined in an open-label dose escalation study, led by Dr. Steven Hersch and Dr. Diana Rosas of Massachusetts General Hospital (MGH), and will be further evaluated in a Phase III clinical trial.

The dose escalation study evaluated HD-02 in a range of doses from 10 to 40 grams per day and successfully determined the optimal dose that provided the maximum efficacy, safety and tolerability. The full scope of the data will be disseminated upon the results being peer reviewed.

Based on these findings, Avicena and its collaborators Dr. Hersch and the Huntington Study Group have developed a double-blind, placebo-controlled Phase III clinical trial anticipated to commence in early 2008. The Phase III trial will be one of the single largest trials for Huntington's patients, with external funding to be announced.

Upon commencement of this clinical trial, Avicena will have advanced three different indications into phase III trials that include some of the largest trial to date in both Parkinson's and Huntington's.

"We are very encouraged by the results of our HD-02 trial and we believe that in conjunction with our collaborators at MGH, we have identified the optimal dose as we move forward to validate HD-02 as a potential treatment for Huntington's disease, for which there is no current approved drug by the FDA.

We are committed to developing therapeutics that we hope can slow the progression of neurodegenerative diseases," stated Belinda Tsao-Nivaggioli, CEO of Avicena.

"We are excited by the results of our studies with HD-02 to date. This Phase III study will evaluat
'"/>




Page: 1 2

Related medicine news :

1. Advances in Treatment of Cataracts
2. Advanced STD programs required
3. Hope For Patients With Advanced Breast Cancer
4. Advances In Stem Cells Research
5. Breast Cancer Advance
6. Canadian Lung Cancer Study Lauded As Major Advance in Cancer Fight
7. Speedier Access To Advances In Breast Cancer Sought For Patients
8. HIV Vaccine Field Trials In Advanced Stage
9. Advance Funeral For AIDS-infected South African
10. New Screening Techniques to Lead Advances In Pain Therapy
11. Twin Treatment Could Be Used Increase Survival Rates In Advanced Melanoma
Post Your Comments:
(Date:5/26/2015)... Pasadena porcelain veneers dentist, Dr. ... cosmetic treatments. Cosmetic dentistry is becoming increasingly popular in ... are committed to providing you with the highest level ... and a smile of a lifetime … We work ... to change your life,” explains Dr. Martirosyan’s team. “Giving ...
(Date:5/26/2015)... May 26, 2015 Indosoft, Inc ... upgrade of the DMi Partners contact center ... the first in Indosoft's contact center ACD system to ... screen support for such trunk features as diversion headers, ... management, and included upgrades to warm transfers ...
(Date:5/26/2015)... May 26, 2015 National Prevention Week ... year. It is supported by the Substance Abuse ... raising public awareness of, and action about, substance abuse ... organizations and coalitions are encouraged to join in promoting ... and related issues, and in building community partnerships. , ...
(Date:5/26/2015)... i2i Systems, the leader in integrated Population ... years, has earned 2014 Patient Centered Medical Home prevalidation ... for its flagship product i2iTracks , the company ... we have done to create healthier populations for so ... NCQA once again,” said Janice Nicholson, co-founder and CEO ...
(Date:5/26/2015)... Award-winning travel photographer and life coach Raul Espinoza creates ... connect viewers to the beauty of the world while making ... Raul has traveled the world documenting lives, and then shared ... bounded by our circumstances. , “KAWSAY” means “life” ... The photo gallery show by the same name will support ...
Breaking Medicine News(10 mins):Health News:Pasadena Porcelain Veneers Expert, Marine Martirosyan DDS, is Now Offering Complimentary Dental Cleaning with Cosmetic Treatments 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 3Health News:Narconon Arrowhead Takes Part in National Prevention Week 2Health News:Narconon Arrowhead Takes Part in National Prevention Week 3Health News:i2iTracks Earns NCQA 2014 PCMH Prevalidation 2Health News:i2iTracks Earns NCQA 2014 PCMH Prevalidation 3Health News:A Photographer & Two Educational Organiazations Join to Make a Difference in Our Youth 2
... Life Sciences has submitted an application with the Drug ... phase-1 clinical trials of its new drug Suvn-502 for ... ,'Treatment for Alzheimer's disease and Schizophrenia is ... to discover drugs that address significant unmet medical needs,' ...
... Nepalese doctors has developed a drug that is more ... reported Friday . ,The drug also costs ... Organization (WHO), reported The Himalayan Times daily.Doctors at the ... typhoid patients. ,,The team compared the effectiveness ...
... 1,763 food shipments from India, 1,480 from Mexico and 1,368 ... year . ,Some of India's spices, seeds and ... found too filthy to eat. Chinese products like seafood, bean ... has reported. ,,But the FDA did not reveal the ...
... for the high-tech dental lasers used mainly to prepare cavities ... conducted by researchers in Austria, these advanced dental lasers can ... study credits the progress of miniaturized, flexible fiber tips for ... treatment. ,Dr. Ulrich Schoop and a team of ...
... on the Yamuna River that flows past India's capital, it's easy ... surface by rotting sewage -- and that's after at least ... ,Now, with New Delhi to host the Commonwealth Games in ... built on the stinking river's banks, India must do in three ...
... the end of the last century death rates from breast ... Long waiting lists, resulting in delayed diagnosis and treatment, were ... is failing breast cancer patients and needs to be reviewed ... brought in the 2 week wait rule which stipulated that ...
Cached Medicine News:Health News:US Rejects More Food from India Than from Any Other Country 2Health News:Millions Spent, but the Indian Capital's River Still Stinks 2Health News:Millions Spent, but the Indian Capital's River Still Stinks 3Health News:Two Week Wait Rule Not Working With Breast Cancer Patients 2
(Date:5/26/2015)... Sanomedics, Inc. (OTC: SIMH) an international medical technology company ... growing behavioral health sector with the strategic acquisition of ... as a Services (SaaS) provider, specialized in Electronic Health ... centers. "The strategic acquisition of Zen ... health sector where the number of treatment service and ...
(Date:5/26/2015)... , May 26, 2015  MGC Diagnostics Corporation (NasdaqCM: MGCD), ... to discuss its financial results for the second quarter of ... at 4:30 p.m. ET on Tuesday, June 2, 2015. The ... fiscal 2015 at the close of the markets on Tuesday, ... 317-6789 or (412) 317-6789 to access the conference call, or ...
(Date:5/26/2015)... 2015 Boehringer Ingelheim today announced that ... once-daily STIOLTO™ RESPIMAT ® (tiotropium bromide and ... a long-term, once-daily maintenance treatment of airflow obstruction ... including chronic bronchitis and/or emphysema. STIOLTO RESPIMAT is ... of COPD. COPD, which includes chronic ...
Breaking Medicine Technology:Sanomedics Targeting Behavioral Health and Electronic Health Records with Strategic Acquisition of Zen Charts 2Sanomedics Targeting Behavioral Health and Electronic Health Records with Strategic Acquisition of Zen Charts 3MGC Diagnostics Corporation to Report Second Quarter Fiscal 2015 Financial Results on Tuesday, June 2, 2015 2FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 2FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 3FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 4FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 5FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 6FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 7FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 8FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 9FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 10FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 11FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 12FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 13
... 2012  Vitamin Shoppe, Inc. (NYSE: VSI ), ... products, today announced that it will be participating at ... Retail Conference taking place March 7 - 8, 2012 ... be Mike Archbold, President and COO and Brenda Galgano, ...
... Feb. 29, 2012 Talyst , a leader in ... annual 340B Coalition Winter Conference. The new tool allows health ... The 340B Savings Calculator lets health systems predict their ... "Talyst is dedicated to ensure you receive ...
Cached Medicine Technology:Vitamin Shoppe, Inc. Announces Participation at Investor Conference 2
... In 2000, Applied Biosystems introduced ... I S M 3100 Genetic Analyzer.,Now ... instrument is available in our new ... for low- to-medium-throughput laboratory needs, the ...
... Quality Analysis System) developed by Pablo Artal, ... first diagnostic tool for ophthalmology that provides ... system. Never before has an ophthalmologist had ... quality of vision. , ,OQAS works by ...
... kit uses proteins produced with recombinant technology, that ... which are capable of detecting the different types ... are proteins with amino acid sequences repeated in ... the acute phase of the infection, it reacts ...
Elisa test for qualitative detection of Total antibodies to Trypanosoma Cruzi in human serum or plasma....
Medicine Products: